Geffen Residence & Renewal Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 6

Employees

  • Stock Symbol
  • GEFR

Stock Symbol

  • Share Price
  • $0.24
  • (As of Thursday Closing)

Geffen Residence & Renewal General Information

Description

Geffen Residence & Renewal Ltd is engaged in the field of Real Estate and especially in the field of Urban Renewal.

Contact Information

Formerly Known As
Proteologics, Cannomed Medical Cannabis Industries
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 8 Hamanofim
  • Herzliya 4672559
  • Israel
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
TAE
Corporate Office
  • 8 Hamanofim
  • Herzliya 4672559
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Geffen Residence & Renewal Stock Performance

As of 19-Nov-2026, Geffen Residence & Renewal’s stock price is $0.24. Its current market cap is $98.4M with 411M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.24 $0.24 $0.21 - $0.29 $98.4M 411M 181K

Geffen Residence & Renewal Financials Summary

As of 30-Jun-2026, Geffen Residence & Renewal has a trailing 12-month revenue of $24.8K.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 120,740 101,025 50,466 16,611
Revenue 25 22 35 38
EBITDA (2,544) (1,977) (1,776) (1,731)
Net Income (1,841) (1,474) (1,360) (1,865)
Total Assets 111,696 83,171 28,007 27,870
Total Debt 23,074 16,859 12,270 11,926
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Geffen Residence & Renewal Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Geffen Residence & Renewal‘s full profile, request access.

Request a free trial

Geffen Residence & Renewal Patents

Geffen Residence & Renewal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2013088445-A1 Pyrimidine derivatives for treatment of inflammatory diseases Inactive 13-Dec-2011
WO-2013042120-A2 Synthetic ubiquitins and use thereof in drug screening assays Inactive 19-Sep-2011
WO-2013042120-A3 Synthetic ubiquitins and use thereof in drug screening assays Inactive 19-Sep-2011
AU-2010322800-A1 Small pyrimidine derivatives and methods of use thereof Inactive 30-Nov-2009
CA-2782146-A1 Small pyrimidine derivatives and methods of use thereof Inactive 30-Nov-2009 A61K31/497
To view Geffen Residence & Renewal’s complete patent history, request access »

Geffen Residence & Renewal Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Geffen Residence & Renewal Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Geffen Residence & Renewal‘s full profile, request access.

Request a free trial

Geffen Residence & Renewal ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Food Products

Industry

Rank

Percentile

Agriculture

Subindustry

Rank

Percentile

To view Geffen Residence & Renewal’s complete esg history, request access »

Geffen Residence & Renewal FAQs

  • When was Geffen Residence & Renewal founded?

    Geffen Residence & Renewal was founded in 1999.

  • Where is Geffen Residence & Renewal headquartered?

    Geffen Residence & Renewal is headquartered in Herzliya, Israel.

  • What is the size of Geffen Residence & Renewal?

    Geffen Residence & Renewal has 6 total employees.

  • What industry is Geffen Residence & Renewal in?

    Geffen Residence & Renewal’s primary industry is Drug Discovery.

  • Is Geffen Residence & Renewal a private or public company?

    Geffen Residence & Renewal is a Public company.

  • What is Geffen Residence & Renewal’s stock symbol?

    The ticker symbol for Geffen Residence & Renewal is GEFR.

  • What is the current stock price of Geffen Residence & Renewal?

    As of 19-Nov-2026 the stock price of Geffen Residence & Renewal is $0.24.

  • What is the current market cap of Geffen Residence & Renewal?

    The current market capitalization of Geffen Residence & Renewal is $98.4M.

  • What is Geffen Residence & Renewal’s current revenue?

    The trailing twelve month revenue for Geffen Residence & Renewal is $24.8K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process